These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 9881650)

  • 1. Pharmacokinetic analysis program based on tank-in-series model, MULTI(TIS), for evaluation of capacity-limited local disposition.
    Fukumura K; Yamaoka K; Higashimori M; Nakagawa T
    Biol Pharm Bull; 1998 Dec; 21(12):1338-43. PubMed ID: 9881650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis program based on finite element method, MULTI(FEM), for evaluation of dose-dependent local disposition of drug in liver.
    Fukumura K; Yamaoka K; Higashimori M; Nakagawa T
    J Pharm Sci; 1999 May; 88(5):538-43. PubMed ID: 10229646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative evaluation of capacity-limited hepatobiliary transport based on hepatocellular diffusion model by MULTI(FEM).
    Higashimori M; Yamaoka K; Fujitani S; Nakagawa T
    J Pharmacokinet Pharmacodyn; 2001 Oct; 28(5):415-44. PubMed ID: 11768289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependency in local disposition of 5-fluorouracil under non-steady-state condition in rat liver.
    Higashimori M; Yamaoka K; Nakagawa T
    J Pharm Sci; 2000 Jan; 89(1):100-7. PubMed ID: 10664542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of protein binding effect on local disposition of oxacillin in rat liver by a two-compartment dispersion model.
    Yano Y; Yamaoka K; Minamide T; Nakagawa T; Tanaka H
    J Pharm Pharmacol; 1990 Sep; 42(9):632-6. PubMed ID: 1981901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consideration on moments of outflow profile in liver perfusion system with change in perfusate flow rate using oxacillin as model drug.
    Ohata Y; Yamaoka K; Yasui H; Nakagawa T
    Biol Pharm Bull; 1996 Jan; 19(1):83-7. PubMed ID: 8820917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two-compartment dispersion model for analysis of organ perfusion system of drugs by fast inverse Laplace transform (FILT).
    Yano Y; Yamaoka K; Aoyama Y; Tanaka H
    J Pharmacokinet Biopharm; 1989 Apr; 17(2):179-202. PubMed ID: 2795455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of perfusion rate on the local disposition of cefixime in liver perfusion system based on two-compartment dispersion model.
    Yano Y; Yamaoka K; Yasui H; Nakagawa T
    Drug Metab Dispos; 1991; 19(6):1022-7. PubMed ID: 1687006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of liver intoxication by carbon tetrachloride on hepatic local disposition of oxacillin using moment characteristics as index.
    Yasui H; Yamaoka K; Fukuyama T; Nakagawa T
    Drug Metab Dispos; 1995 Aug; 23(8):779-85. PubMed ID: 7493542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of pentobarbital anaesthesia on intestinal absorption and hepatic first-pass metabolism of oxacillin in rats, evaluated by portal-systemic concentration difference.
    Ueda S; Yamaoka K; Nakagawa T
    J Pharm Pharmacol; 1999 May; 51(5):585-9. PubMed ID: 10411218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of capacity-limited first-pass effect through liver by three-points sampling in portal and hepatic veins and systemic artery.
    Ueda S; Yamaoka K; Yui J; Shigematsu A; Nakagawa T
    Pharm Res; 2002 Jun; 19(6):852-7. PubMed ID: 12134957
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moment analysis of intestinal first-pass metabolism by portal-systemic concentration difference in single conscious rat using 5'-deoxy-5-fluorouridine and 5-fluorouracil as model drug system.
    Sawai Y; Yamaoka K; Takemura A; Nakagawa T
    J Pharm Sci; 1997 Nov; 86(11):1269-72. PubMed ID: 9383738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local disposition of a new xanthine oxidase/xanthine dehydrogenase inhibitor, BOF-4272, in rat liver.
    Nishimura M; Yamaoka K; Yasui H; Naito S; Nakagawa T
    Biol Pharm Bull; 1994 Sep; 17(9):1301-4. PubMed ID: 7841959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicokinetic modeling of dose-dependent formate elimination in rats: in vivo-in vitro correlations using the perfused rat liver.
    Damian P; Raabe OG
    Toxicol Appl Pharmacol; 1996 Jul; 139(1):22-32. PubMed ID: 8685905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic analysis of the disposition of valproate in pregnant rats.
    Kobayashi S; Takai K; Iga T; Hanano M
    Drug Metab Dispos; 1991; 19(5):972-6. PubMed ID: 1686245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis methods and recent advances in nonlinear pharmacokinetics from in vitro through in loci to in vivo.
    Yamaoka K; Takakura Y
    Drug Metab Pharmacokinet; 2004 Dec; 19(6):397-406. PubMed ID: 15681893
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disposition analysis by fast inverse Laplace transform (FILT)].
    Yamaoka K
    Yakugaku Zasshi; 1992 Aug; 112(8):503-15. PubMed ID: 1432601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic local disposition of a drug with high protein binding and high hepatic clearance using BOF-4272 as a model drug.
    Nishimura M; Yamaoka K; Naito S; Nakagawa T
    Biol Pharm Bull; 1996 Sep; 19(9):1197-202. PubMed ID: 8889040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A nonlinear least squares program, MULTI(FILT), based on fast inverse Laplace transform for microcomputers.
    Yano Y; Yamaoka K; Tanaka H
    Chem Pharm Bull (Tokyo); 1989 Apr; 37(4):1035-8. PubMed ID: 2766405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of temperature in perfusate on local hepatic disposition of BOF-4272, a new xanthine oxidase inhibitor.
    Nishimura M; Yamaoka K; Yasui H; Naito S; Nakagawa T
    Biol Pharm Bull; 1995 Jul; 18(7):980-3. PubMed ID: 7581254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.